Skip to main content
Premium Trial:

Request an Annual Quote

Israeli Personalized Medicine Center Gets $50M Donation

NEW YORK (GenomeWeb News) – The Weizmann Institute of Science has received a $50 million donation to fund operations at the new Israel National Center for Personalized Medicine (INCPM), which is located at the Weizmann campus in Rehovot, Israel.

The INCPM is focused on conducting research involving genomics, protein profiling, bioinformatics, and drug discovery to advance new personalized approaches to diagnosing, treating, and preventing diseases.

The American Committee for the Weizmann Institute of Science said today that Nancy and Stephen Grand committed the funding, and that the INCPM has incorporated the Grand name into its own.

Now named the Nancy and Stephen Grand INCPM, the center is a national consortium that serves Israel's life sciences research community, hospitals, and industry. It will engage in international collaborations and "[draw] upon Israel's diverse genetic pool comprised of populations from around the globe," the committee said.

The institute is composed of the Crown Institute for Genomics; the de Botton Institute for Protein Profiling; the Wohl Institute for Drug Discovery; and the Mantoux Bioinformatics Institute.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.